Subsequently, functional experiments showed that MYH9 promoted proliferation, migration of ccRCC cells in vitro and in vivo, which suggested that MYH9 might act as a cancer promoter in ccRCC. Here, MYH9 is linked to nonpapillary renal cell carcinoma.